Vaccines with Aluminum-containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability

This publication has 70 references indexed in Scilit:

• T‐helper 1 and T‐helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection
  Immunology, 2009
• Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry
  Journal of Pharmaceutical Sciences, 2009
• Stability of a Trivalent Recombinant Protein Vaccine Formulation Against Botulinum Neurotoxin During Storage in Aqueous Solution
  Journal of Pharmaceutical Sciences, 2009
• Towards an understanding of the adjuvant action of aluminium
  Nature Reviews Immunology, 2009
• Mechanism of action of clinically approved adjuvants
  Current Opinion in Immunology, 2009
• The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activity
  European Journal of Immunology, 2008
• Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
  Nature Immunology, 2008
• Preparation of Active Proteins, Vaccines and Pharmaceuticals as Fine Powders using Supercritical or Near-Critical Fluids
  Pharmaceutical Research, 2008
• Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
  The Journal of Experimental Medicine, 2008
• Considerable Differences in Vaccine Immunogenicities and Efficacies Related to the Diluent Used for Aluminum Hydroxide Adjuvant
  Clinical and Vaccine Immunology, 2008